The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.

The adoption of generic semaglutide in India hinges on the clarity and simplicity of its delivery devices.

Discover how the Semaglutide episode could reshape India's generics sector, revealing vulnerabilities and opportunities for future growth.

The approval is to treat Type II diabetes

South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement diet and exercise for adults. The company…

Sun Pharma receives SAHPRA approval to market a generic semaglutide injection for type 2 diabetes in South Africa.

South Africa is now the second market, after India, where the company has secured clearance for a generic semaglutide injection